Causes and Management of Agitation and Aggression in Dementia
Non-pharmacological interventions should be considered as first-line treatment for agitation and aggression in dementia, with pharmacological approaches reserved for cases where non-pharmacological methods are insufficient or when there is significant risk of harm. 1, 2, 3
Causes of Agitation and Aggression in Dementia
Agitation and aggression in dementia result from multiple interacting factors:
- Neurobiological changes: These symptoms are closely linked to the underlying brain disease causing cognitive symptoms 1
- Unmet needs: Behaviors often stem from unmet physical or emotional needs that patients cannot effectively communicate 1, 2
- Environmental factors: Overstimulation, changes in routine, or unfamiliar environments can trigger agitation 1, 2
- Medical conditions: Pain, infections (especially urinary tract infections), and other physical discomfort are common triggers 1, 3
- Medication side effects: Certain medications can worsen cognitive symptoms and contribute to behavioral disturbances 3
Assessment Approach
Before implementing any intervention:
- Assess the type, frequency, severity, pattern, and timing of symptoms 1
- Evaluate for pain and other potentially modifiable contributors to symptoms 1, 2
- Consider the subtype of dementia, which may influence treatment choices 1, 3
- Use the ABC (antecedent-behavior-consequence) approach to identify triggers 2, 3
- Document a comprehensive treatment plan that includes appropriate person-centered interventions 1
Non-Pharmacological Interventions
First-Line Approaches:
Environmental Modifications:
Communication Strategies:
Personalized Activities:
Multidisciplinary Care:
Pharmacological Management
Medications should only be used when:
- Non-pharmacological interventions have been ineffective 1, 2
- Symptoms are severe, dangerous, or cause significant distress 1
- There is clear risk of harm to the patient or others 3
Medication Options:
Atypical Antipsychotics:
- Consider for severe behavioral symptoms with psychotic features 2, 3
- Show modest but significant improvement in aggression in the short term (6-12 weeks) 6
- Start at low doses and titrate to minimum effective dose 1
- Monitor closely for adverse effects and consider discontinuation after 4 weeks if no response 1
- Be aware of increased mortality risk with prolonged use 6
Alternative Medications with Preliminary Evidence:
Monitoring and Follow-up
- Assess response to treatment with quantitative measures 1
- Evaluate pharmacological interventions within 30 days 2, 3
- Consider tapering or discontinuing medications after 6 months of symptom stabilization 2, 3
- Regularly reassess the need for continued medication as symptoms fluctuate 2
Common Pitfalls to Avoid
- Relying exclusively on medications without implementing non-pharmacological strategies 2, 3
- Using medications with significant anticholinergic effects 2, 3
- Failing to monitor for medication side effects 2, 3
- Underestimating the role of pain and discomfort as causes of agitation 2, 5
- Continuing antipsychotic medication beyond 4 weeks when there is no clinically significant response 1
Treatment Algorithm
Initial Assessment:
First-Line: Non-pharmacological Approaches:
Second-Line: Pharmacological Treatment (if needed):
Ongoing Monitoring: